Breaking News

Obagi Medical Products, Inc. appointed Mark T. Taylor as senior vice president,

February 1, 2013

Obagi Medical Products, Inc.: appointed Mark T. Taylor as senior vice president, corporate development and investor relations. He comes to Obagi with more than 20 years of experience working with specialty pharmaceutical companies in high-level capacities. Most recently, Taylor was at Roth Capital Partners, LLC where, for over a six-year tenure, he served health care clients in institutional sales, investment banking and equity research. From May of 2003 to October of 2007, he was Roth’s specialty pharmaceutical analyst where he published on as many as 25 companies, including Obagi.
blog comments powered by Disqus
  • Patent Update

    Patent Update

    June 30, 2016
    J&J's anti-aging patent, LVMH and cannabis essential oil, transdermal botulinum toxins and more in recent patent news.

  • Start Stuffing The Ballot Box (Again)!

    Start Stuffing The Ballot Box (Again)!

    June 28, 2016
    Vote on the finalists in Happi's reader's choice Anti-Aging Product of the Year contest!

  • What

    What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 27, 2016
    Euromonitor weighs in on how Brexit could impact consumer product companies.

  • The Top 50

    The Top 50

    June 30, 2016
    A look at the biggest US companies in the global household and personal products industry.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.